Order Article Reprints

Behrouzi R, Ryan NAJ, Barr CE, Derbyshire AE, Wan YL, Maskell Z, Stocking K, Pemberton PW, Bolton J, McVey RJ, et al. Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer. Cancers. 2020; 12(2):276. https://doi.org/10.3390/cancers12020276

Behrouzi, Roya, Neil A. J. Ryan, Chloe E. Barr, Abigail E. Derbyshire, Y. Louise Wan, Zoe Maskell, Katie Stocking, Philip W. Pemberton, James Bolton, Rhona J. McVey, and et al. 2020. "Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer" Cancers 12, no. 2: 276. https://doi.org/10.3390/cancers12020276

Behrouzi, R., Ryan, N. A. J., Barr, C. E., Derbyshire, A. E., Wan, Y. L., Maskell, Z., Stocking, K., Pemberton, P. W., Bolton, J., McVey, R. J., & Crosbie, E. J. (2020). Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer. Cancers, 12(2), 276. https://doi.org/10.3390/cancers12020276